Products Imported As Supplements Contain Anticonvulsants, Cholesterol Drugs
This article was originally published in The Tan Sheet
Executive Summary
A July 15 import alert states that FDA and U.S. Customs officials can detain without physical examination certain imports from 20 foreign firms, including 14 from China.
You may also be interested in...
Adverse Event Contact, GMPs Send Foreign Supplement Firms To Import Alerts
Products linked to both GMP and labeling problems were identified on "detention without physical examination" import alerts. Firms from Australia, Italy, Norway and Romania were added in FDA's latest alert update.
Senators Push Park Doctrine Prosecution For Spiked Supplement ‘Criminal Endeavors’
Key industry allies say they are “deeply concerned” about “blatant criminal activity” in products marketed as supplements but containing anabolic steroids or other drugs. “Bring a few of these actions and you scare people into the idea that … you could actually go to jail,” says attorney Frederick Stearns.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.